Consolidated Statements of Operations - USD ($)		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024
Income Statement [Abstract]
Revenues
Operating expenses
Research and development		1,060,191	2,130,385
General and administrative		2,174,751	2,088,776
Total operating expenses		3,234,942	4,219,161
Loss from operations		(3,234,942)	(4,219,161)
Other income
Change in fair value of warrant liability		3,967	51,081
Interest income		121,984	55,660
Total other income		125,951	106,741
Net loss		(3,108,991)	(4,112,420)
Deemed dividend on warrant inducements			(3,212,504)
Net loss attributable to common stockholders		$ (3,108,991)	$ (7,324,924)
Weighted average shares outstanding - basic	[1]	1,174,869	252,960
Weighted average shares outstanding - diluted	[1]	1,174,869	252,960
Loss per share - basic	[1]	$ (2.65)	$ (28.96)
Loss per share - diluted	[1]	$ (2.65)	$ (28.96)

[1] Adjusted to reflect the reverse stock split as described in Note 1.